Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complete Pathological Response”

341 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 341 results

Not applicableActive Not RecruitingNCT06087718
What this trial is testing

Feasibility of the Maastro Applicator in Rectal Cancer

Who this might be right for
Rectal CancerFeasibilityToxicity+5 more
Maastricht Radiation Oncology 10
Not applicableUnknownNCT05750693
What this trial is testing

PIK3CA in HER2+ BC and pCR Trial

Who this might be right for
HER2-positive Breast Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 58
Not applicableUnknownNCT01863862
What this trial is testing

Organ Preservation in Elderly Patients With Rectal Cancer

Who this might be right for
Rectal Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 90
Not applicableUnknownNCT02600442
What this trial is testing

Assessment of Breast Cancer Response to Neoadjuvant Anthracycline-based Chemotherapy by FDG-PET and Molecular Markers

Who this might be right for
Breast NeoplasmsBreast Cancer
Assistance Publique - Hôpitaux de Paris 168
Testing effectiveness (Phase 2)Looking for participantsNCT07646301
What this trial is testing

Iparomlimab and Tuvonralimab Plus Paclitaxel and Platinum as Neoadjuvant Therapy for Locally Advanced Cervical Cancer

Who this might be right for
Uterine Cervical NeoplasmsLocally Advanced
Sun Yat-sen University 103
Not applicableLooking for participantsNCT06451393
What this trial is testing

Predicting Gastric Cancer Response to Chemo With Multimodal AI Model

Who this might be right for
Gastric CancerChemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University 500
Testing effectiveness (Phase 2)WithdrawnNCT06180863
What this trial is testing

Oral Azacitidine (CC-486) Epigenetic Priming and Maintenance for Adult Acute Myeloid Leukemia (AML) Patients

Who this might be right for
Acute Myeloid Leukemia
Yale University
Not applicableLooking for participantsNCT05505357
What this trial is testing

Omission of Breast Surgery for Breast Cancer Patients With pCR on MRI and Vacuum-assisted Biopsy After NST (OPTIMIST)

Who this might be right for
Breast Cancer Invasive
Seoul National University Hospital 533
Not applicableStudy completedNCT03539965
What this trial is testing

Triple-negative Breast Cancer: a New Perspective on Biomarkers

Who this might be right for
Triple Negative Breast NeoplasmsTriple Negative Breast Cancer
Instituto Nacional de Cancer, Brazil 239
Not applicableUnknownNCT05642767
What this trial is testing

Molecular Detection Of Efflux Pump and Virulence Factors Genes in Pseudomonas Aeruginosa

Who this might be right for
Pseudomonas Aeruginosa
Sohag University 75
Testing effectiveness (Phase 2)Study completedNCT00828672
What this trial is testing

Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer
Universitaire Ziekenhuizen KU Leuven 84
Not applicableStudy completedNCT06996301
What this trial is testing

Clinical Utility of a PCR Compared to Culture and Sensitivity Testing for the Management of cUTI in Adults.

Who this might be right for
Urinary Tract Infection ComplicatedUrinary Tract Infection (cUTI)Urinary Tract Infection (Diagnosis)
Doc Lab Inc 773
Not applicableNot Yet RecruitingNCT07475338
What this trial is testing

Effect of Storytelling on Questionnaire Completion and Quality of Collected Data in an E-Cohort

Who this might be right for
General Population (no Specific Condition or Disease)
SKEZI 500
Not applicableEnded earlyNCT01073436
What this trial is testing

Discontinuation of Imatinib Mesylate in Patients With Chronic-Phase Chronic Myeloid Leukemia Previously Treated With Interferon-Alpha

Who this might be right for
Chronic Myeloid Leukemia
University of Michigan Rogel Cancer Center 7
Large-scale testing (Phase 3)Ended earlyNCT00519090
What this trial is testing

Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP)

Who this might be right for
Myelogenous Leukemia
Novartis Pharmaceuticals 6
Large-scale testing (Phase 3)Temporarily pausedNCT05503108
What this trial is testing

Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer

Who this might be right for
Fasting Mimicking DietHER2-negative Breast CancerHormone Receptor-positive Breast Cancer+3 more
Leiden University Medical Center 10
Not applicableNot Yet RecruitingNCT07673211
What this trial is testing

Circulating cfDNA and HPV as Prognostic Biomarkers for First-Line Recurrent Metastatic Cervical Cancer

Who this might be right for
Cervical CancerRecurrent Cervical CancerMetastatic Cervical Cancer
Zhejiang Cancer Hospital 60
Not applicableNot Yet RecruitingNCT07516626
What this trial is testing

Patient-Derived Organoids to Functionally Characterize Chemotherapy Resistance in Breast Cancer

Who this might be right for
Breast CancerLocally Advanced Breast Cancer (LABC)
Atlas University 40
Testing effectiveness (Phase 2)Study completedNCT00858806
What this trial is testing

Intermittent Imatinib Treatment in Chronic Myeloid Leukemia and Philadelphia Chromosome (Ph+CML) Patients Who Achieved a Complete Cytogenetic Response (CCgR) on Standard Imatinib Therapy

Who this might be right for
Chronic Myeloid Leukemia
Università degli Studi di Brescia 78
Large-scale testing (Phase 3)Study completedNCT01216644
What this trial is testing

5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Krankenhaus Nordwest 716
Next Page